Prestigious Prize Honors Pioneering Immune System Research

The prestigious award in medical science was granted for revolutionary findings that clarify how the body's defense network targets dangerous pathogens while protecting the healthy tissues.

A trio of renowned scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—share this honor.

Their work identified specialized "security guards" within the defense system that remove malfunctioning defense cells capable of attacking the body.

These discoveries are now paving the way for new treatments for autoimmune diseases and malignancies.

The winners will divide a prize fund worth 11m Swedish kronor.

Crucial Findings

"Their work has been decisive for understanding how the immune system operates and the reason we don't all suffer from severe self-attack conditions," stated the chair of the Nobel Committee.

The team's studies explain a core mystery: How does the defense system protect us from numerous infections while keeping our own tissues unharmed?

Our immune system uses white blood cells that scan for indicators of infection, even viruses and germs it has never encountered.

These cells employ detectors—called receptors—that are produced by chance in countless variations.

That gives the immune system the ability to fight a wide array of threats, but the unpredictability of the mechanism inevitably creates immune cells that may target the body.

Security Guards of the Immune System

Researchers earlier knew that a portion of these harmful defense cells were destroyed in the thymus—where white blood cells mature.

The latest award recognizes the identification of regulatory T-cells—known as the body's "security guards"—which patrol the system to disarm other defenders that attack the body's own tissues.

It is known that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel added, "The discoveries have laid the foundation for a new field of investigation and spurred the creation of new treatments, for example for cancer and autoimmune diseases."

Regarding cancer, T-regs block the body from attacking the tumor, so research are aimed at reducing their numbers.

In self-attack disorders, trials are exploring boosting regulatory T-cells so the organism is no longer under attack. A comparable method could also be useful in reducing the chances of transplanted organ rejection.

Pioneering Studies

Prof Shimon Sakaguchi, from Osaka University, performed experiments on rodents that had their thymus removed, causing self-attack conditions.

He demonstrated that introducing defense cells from other animals could stop the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in rodents and humans that resulted in the identification of a gene vital for the way regulatory T-cells function.

"Their pioneering work has uncovered how the body's defenses is controlled by T-reg cells, preventing it from accidentally targeting the healthy cells," said a prominent physiology specialist.

"This research is a striking illustration of how basic physiological study can have broad consequences for human health."